PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Université de Paris, INSERM, IAME, F-75006 Paris, France.\', \'AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.\', \'AP-HP Nord, Department of Epidemiology, Biostatistics and Clinical Research, Bichat-Claude Bernard University Hospital, Paris, France.\', \'AP-HP Nord, Infectious Diseases Department, Bichat-Claude Bernard University Hospital, Paris, France.\', \'AP-HP Nord, Bacteriology, Bichat-Claude Bernard University Hospital, Paris, France.\', \'AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.\', \'AP-HP Nord, Infection Control Unit, Bichat-Claude Bernard University Hospital, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/jac/dkab241
?:hasPublicationType
?:journal
  • The Journal of antimicrobial chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34555158
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all